22nd Century Group Q2FY26 Results: Revenue falls 29% QoQ to $2.9 million

scanx
Reviewed by
Riya DScanX News Team
Key Highlights
  • Net revenue fell 29% QoQ to $2.9 million as legacy contract business winds down
  • Net loss widened to $3.3 million from $3.0 million in the prior quarter
  • Gross loss narrowed to $0.3 million from $0.6 million, aided by non-recurring tax recovery
  • Company targets expansion to 5,000 retail outlets by end of 2026
  • Cash position stands at $6.1 million with zero outstanding debt
powered bylight_fuzz_icon
51541710

*this image is generated using AI for illustrative purposes only.

22nd Century Group (NASDAQ: XXII) reported second-quarter fiscal 2026 net revenue of $2.9 million, a 29% sequential decline from $4.1 million in Q1FY26. The drop reflects the company’s strategic exit from low-margin contract manufacturing business.

The company recorded a net loss from continuing operations of $3.3 million for the quarter, compared to a loss of $3.0 million in the prior quarter. Gross margin remained negative, though the gross loss narrowed to $0.3 million from $0.6 million in Q1FY26.

Financial Performance

Revenue for the first half of FY26 stood at $7.0 million, down from $10.0 million in the same period last year. Management attributed the top-line contraction to an intentional transformation away from legacy contract manufacturing toward higher-margin branded products, specifically its Pinnacle and VLN (reduced nicotine) portfolios.

Metric Q2FY26 Q1FY26 Change
Net Revenue $2.9 million $4.1 million -29%
Gross Loss $0.3 million $0.6 million Narrowed
Net Loss $3.3 million $3.0 million Widened
Adjusted EBITDA -$3.5 million -$2.6 million Wider loss

The gross loss improvement was aided by two non-recurring items: a one-time charge of approximately $196,000 for aged inventory write-offs and an offsetting excise tax recovery of roughly $692,000. Excluding these items, the underlying gross margin trajectory remains under pressure as the company winds down uneconomic volume.

What the Numbers Show

The divergence between narrowing gross losses and widening operating losses highlights the fixed-cost burden during this transition. While gross loss halved sequentially due to pricing discipline and mix shifts, operating expenses absorbed most of the benefit, resulting in a wider net loss. This indicates that while revenue quality is improving, the scale required to cover fixed overheads has not yet been achieved through branded sales alone.

Strategic Shift and Distribution

Management emphasized a shift from volume-driven contract manufacturing to a branded platform led by Pinnacle VLN cigarettes. The company aims to expand its retail presence from approximately 2,000 stores across 20 states to 5,000 outlets across 35 states by year-end 2026.

Key commercial developments include:

  • New distribution agreements in metro New York and northern New Jersey, adding nearly 150 high-visibility store locations.
  • Launch of Pinnacle Pure, targeting the premium tier 2 cigarette category.
  • Pricing adjustments to reflect true manufacturing economics, leading to the loss of some low-margin customers.

Balance Sheet and Outlook

As of the end of Q2FY26, the company held $6.1 million in cash and cash equivalents with no outstanding debt. Capital allocation remains focused on distribution growth and marketing initiatives for the Pinnacle portfolio.

CEO Larry Firestone stated that shipments of branded products in the second half of 2026 are expected to be significantly larger than in the first half. The company anticipates that the majority of remaining legacy contract manufacturing volume will be wound down by early Q1FY27.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

How will the company bridge the cash burn gap given only $6.1 million in reserves and no debt, while scaling distribution to 5,000 outlets?

What specific marketing spend or operational efficiencies are planned to offset the widening Adjusted EBITDA loss during the transition period?

How might the launch of Pinnacle Pure impact market share in the premium tier 2 category against established competitors?

like15
dislike

22nd Century Group to attend HC Wainwright Conference in September

scanx
Reviewed by
Riya DScanX News Team
Key Highlights

22nd Century Group (NASDAQ: XXII) confirmed its participation in the HC Wainwright Conference on September 15, 2026. CEO Larry Firestone and CFO Dan Otto will attend. The firm, known for FDA-authorized VLNâ„¢ low-nicotine cigarettes containing 95% less nicotine than traditional tobacco, also released an updated investor presentation.

powered bylight_fuzz_icon
48630856

*this image is generated using AI for illustrative purposes only.

22nd Century Group, Inc. (NASDAQ: XXII) will participate in the HC Wainwright Conference on September 15, 2026, at the Lotte New York Palace Hotel. The tobacco harm reduction company aims to engage with investors through meetings arranged via HC Wainwright representatives.

Larry Firestone, chairman and chief executive officer, and Dan Otto, chief financial officer, will represent the company at the event.

Investor Resources

The company has posted an updated investor presentation online at its investor relations website. This update coincides with the upcoming conference participation.

About 22nd Century Group

22nd Century Group positions itself as a leader in tobacco harm reduction, focusing on enabling smokers to control nicotine consumption. The company highlights its proprietary non-GMO reduced nicotine tobacco plants, which contain 95% less nicotine compared to traditional tobacco plants.

Key product details include:

  • VLNâ„¢ cigarettes: Flagship low nicotine combustible cigarette products.
  • Regulatory Status: VLNâ„¢ is the only low nicotine combustible cigarette authorized by the FDA in the United States.
  • Technology: Patented technologies regulate alkaloid biosynthesis activities to reduce nicotine content while maintaining commercial scalability.

The company states that its products have been proven to allow consumers to greatly reduce their nicotine consumption, offering an authentic alternative for traditional cigarette smokers.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

How might 22nd Century Group's upcoming investor presentation address the timeline for scaling production of VLNâ„¢ cigarettes to meet potential increased demand?

What is the company's strategy for expanding market share in the US given that VLNâ„¢ is currently the only FDA-authorized low nicotine combustible cigarette?

How does management plan to leverage the proprietary non-GMO reduced nicotine technology to defend against emerging competitors or alternative harm reduction products?

like20
dislike

More News on 22nd Century Group